Pages that link to "Q90925362"
Jump to navigation
Jump to search
The following pages link to Ann C Duerr (Q90925362):
Displaying 50 items.
- The use of nonhuman primate models in HIV vaccine development (Q21563403) (← links)
- Coreceptor utilization of HIV type 1 subtype E viral isolates from Thai men with HIV type 1-infected and uninfected wives (Q28216148) (← links)
- HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders (Q28606620) (← links)
- Immunization with cocktail of HIV-derived peptides in montanide ISA-51 is immunogenic, but causes sterile abscesses and unacceptable reactogenicity (Q28749845) (← links)
- Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial (Q28972526) (← links)
- Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women (Q33182358) (← links)
- Safety analysis of the diaphragm in combination with lubricant or acidifying microbicide gels: effects on markers of inflammation and innate immunity in cervicovaginal fluid (Q33399887) (← links)
- Differential specificity and immunogenicity of adenovirus type 5 neutralizing antibodies elicited by natural infection or immunization (Q33558605) (← links)
- Trivalent adenovirus type 5 HIV recombinant vaccine primes for modest cytotoxic capacity that is greatest in humans with protective HLA class I alleles (Q33839468) (← links)
- Evaluating nurses' implementation of an infant-feeding counseling protocol for HIV-infected mothers: The Ban Study in Lilongwe, Malawi (Q33990216) (← links)
- The potential role of biomarkers in HIV preventive vaccine trials (Q34059957) (← links)
- Male viral load and heterosexual transmission of HIV-1 subtype E in northern Thailand (Q34116644) (← links)
- Overview of STEP and Phambili trial results: two phase IIb test-of-concept studies investigating the efficacy of MRK adenovirus type 5 gag/pol/nef subtype B HIV vaccine (Q34373275) (← links)
- Immune-correlates analysis of an HIV-1 vaccine efficacy trial reveals an association of nonspecific interferon-γ secretion with increased HIV-1 infection risk: a cohort-based modeling study (Q34450043) (← links)
- Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial (Q34648825) (← links)
- Serological immunity to adenovirus serotype 5 is not associated with risk of HIV infection: a case–control study (Q34673391) (← links)
- Resistance to HIV-1 infection: lessons learned from studies of highly exposed persistently seronegative (HEPS) individuals (Q35183374) (← links)
- Prevention of perinatal HIV transmission: a review of novel strategies (Q35207628) (← links)
- Breast milk and HIV-1: vector of transmission or vehicle of protection? (Q35598969) (← links)
- Vaginal flora morphotypic profiles and assessment of bacterial vaginosis in women at risk for HIV infection. (Q35614592) (← links)
- A multicenter study of bacterial vaginosis in women with or at risk for human immunodeficiency virus infection (Q35614872) (← links)
- Human adenovirus-specific T cells modulate HIV-specific T cell responses to an Ad5-vectored HIV-1 vaccine (Q35640645) (← links)
- Effect of rAd5-Vector HIV-1 Preventive Vaccines on HIV-1 Acquisition: A Participant-Level Meta-Analysis of Randomized Trials (Q35762443) (← links)
- Safety and Immunogenicity of the MRKAd5 gag HIV Type 1 Vaccine in a Worldwide Phase 1 Study of Healthy Adults (Q36172965) (← links)
- Extended follow-up confirms early vaccine-enhanced risk of HIV acquisition and demonstrates waning effect over time among participants in a randomized trial of recombinant adenovirus HIV vaccine (Step Study) (Q36376210) (← links)
- Reasons for testing and clinical and demographic profile of adolescents with non-perinatally acquired HIV infection (Q36410867) (← links)
- Merck Ad5/HIV induces broad innate immune activation that predicts CD8⁺ T-cell responses but is attenuated by preexisting Ad5 immunity (Q36483435) (← links)
- HIV vaccines: new frontiers in vaccine development (Q36534852) (← links)
- Endpoints and regulatory issues in HIV vaccine clinical trials: lessons from a workshop (Q37194359) (← links)
- Involving communities in the design of clinical trial protocols: the BAN Study in Lilongwe, Malawi (Q37205944) (← links)
- Modifications of a large HIV prevention clinical trial to fit changing realities: a case study of the Breastfeeding, Antiretroviral, and Nutrition (BAN) protocol in Lilongwe, Malawi (Q37464854) (← links)
- Influence of sex hormones, HIV status, and concomitant sexually transmitted infection on cervicovaginal inflammation (Q37865803) (← links)
- Gynaecological conditions associated with HIV infection in women who are partners of HIV-positive Thai blood donors (Q37879471) (← links)
- Risk factors for HIV-1 transmission from HIV-seropositive male blood donors to their regular female partners in northern Thailand (Q37881945) (← links)
- Bacterial vaginosis and HIV seroprevalence among female commercial sex workers in Chiang Mai, Thailand (Q37886528) (← links)
- A Qualitative Assessment of Alcohol Consumption and Sexual Risk Behaviors Among Men Who Have Sex With Men and Transgender Women in Peru. (Q38692742) (← links)
- Integrating family planning and prevention of mother-to-child HIV transmission in resource-limited settings (Q38979155) (← links)
- Adenovirus-based HIV-1 vaccine candidates tested in efficacy trials elicit CD8+ T cells with limited breadth of HIV-1 inhibition (Q39059762) (← links)
- Survival of blood donors and their spouses with HIV-1 subtype E (CRF01 A_E) infection in northern Thailand, 1992-2007. (Q39298952) (← links)
- Maternal mortality among Afghan refugees in Pakistan, 1999-2000. (Q39409781) (← links)
- The acceptability of the female and male condom: a randomized crossover trial (Q39691984) (← links)
- Knowledge and preferences concerning acute HIV testing programs among both Peruvian men who have sex with men and transgender women (Q40384151) (← links)
- Participant retention in clinical trials of candidate HIV vaccines (Q40406434) (← links)
- Seroprevalence of human herpesvirus 8 infection in Northern Thailand (Q40506430) (← links)
- Partner characteristics, intensity of the intercourse, and semen exposure during use of the female condom (Q40605937) (← links)
- Men Who Have Sex With Men in Peru: Acceptability of Medication-Assisted Therapy for Treating Alcohol Use Disorders (Q41412402) (← links)
- Reply to Richie and Villasante (Q42947858) (← links)
- High-risk human papillomavirus reactivation in human immunodeficiency virus-infected women: risk factors for cervical viral shedding. (Q43584971) (← links)
- Abnormal vaginal cytology in HIV-infected and at-risk women after hysterectomy. (Q43597185) (← links)
- Predictors of low CD4 count in resource-limited settings: based on an antiretroviral-naive heterosexual thai population. (Q43979781) (← links)